Novel peptide nanoparticle–biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness-Reference-Cited by-同舟云学术

Novel peptide nanoparticle–biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness

Published:2019-02 Issue:2 Volume:143 Page:669-680.e12
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Grozdanovic Milica,Laffey Kimberly G.,Abdelkarim Hazem,Hitchinson Ben,Harijith Anantha,Moon Hyung-Geon,Park Gye Young,Rousslang Lee K.,Masterson Joanne C.,Furuta Glenn T.,Tarasova Nadya I.,Gaponenko Vadim,Ackerman Steven J.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Eosinophils in asthma;Busse;Ann Allergy,1992

2. Eosinophilic esophagitis;Markowitz;Gastroenterol Clin North Am,2003

3. Small molecule antagonists for chemokine CCR3 receptors;Willems;Med Res Rev,2010

4. Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4;Pease;Expert Opin Drug Discov,2014

5. Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells;Stellato;J Immunol,2001

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inverse Regulation of C–C Chemokine Receptor 3 Oligomerization by Downstream Proteins Indicates Biased Signal Transduction Pathways;The Journal of Physical Chemistry Letters;2024-07-22

2. Critically-ill COVID-19 susceptibility gene CCR3 shows natural selection in sub-Saharan Africans;Infection, Genetics and Evolution;2024-07

3. Sphingosine kinase 1-specific inhibitor PF543 reduces goblet cell metaplasia of bronchial epithelium in an acute asthma model;American Journal of Physiology-Lung Cellular and Molecular Physiology;2024-03-01

4. The airway neuro-immune axis as a therapeutic target in allergic airway diseases;Respiratory Research;2024-02-08

5. IgE directly affects eosinophil migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab;Journal of Allergy and Clinical Immunology;2024-02